A randomised phase III study in advanced oesophageal carcinoma to compare dysphagia in patients treated with radiotherapy versus chemo-radiotherapy.
People with cancer of the oesophagus (gullet) often have trouble swallowing. Radiotherapy can help improve this problem. Using chemotherapy together with radiotherapy may work better but has more side effects. This trial will determine if it is better to use radiotherapy by itself or together with chemotherapy.
Primary Sponsor
Trans Tasman Radiation Oncology Group (TROG)
Collaborating Groups
NCI CTG (ES 2)
Final Accrual
220
Trial Chairperson
Dr Michael Penniment, Royal Adelaide Hospital, SA
Trial Contact
sonya.stephens@health.sa.gov.au
Clinical Trial Registration
Related Post
31 July, 2025
World Lung Cancer Day: Focus on the TROG Lung Working Party
TROG WORKING PARTY IN FOCUS: 31 July 2025 To
29 July, 2025
TROG 21.07 SOCRATES HCC Trial Expands Outreach
TRIAL IN FOCUS: 29 July 2025 We’ve extended the
